Physician

Joseph M Pascuzzo, DO

According to 2025 Medicare claims, Joseph Pascuzzo, DO (NPI: 1538244314) practices medical oncology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is CALIFORNIA CANCER ASSOCIATES FOR RESEARCH AND EXCELLENCE INC (NPI: 1083661607; TIN: 770324589) and primary practice location at 93720-3347.

Pascuzzo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 951 traditional Medicare patients, billed 632,609 HCPCS/CPT codes, and received $4,665,194 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 1,567 prescription claims across 322 beneficiaries totaling $3,799,551 in drug costs, led by Lenalidomide (Lenalidomide). 2023 DME data shows 110 claims. Open Payments data shows 79 records totaling $2,114. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,227,879 to $3,799,551. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	871	876,195	$3,544,598
2016	977	907,528	$4,428,937
2017	879	766,980	$4,128,375
2018	901	644,502	$3,600,160
2019	809	770,983	$4,582,406
2020	998	676,274	$4,122,019
2021	1,007	856,016	$4,721,342
2022	1,073	820,276	$4,933,877
2023	1,123	722,400	$4,858,504
2024	951	632,609	$4,665,194

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	225	1,781	$1,227,879
2016	251	1,772	$1,098,235
2017	236	1,656	$1,343,088
2018	267	1,874	$1,456,484
2019	271	1,680	$1,350,311
2020	274	1,599	$1,989,937
2021	286	1,650	$2,803,569
2022	288	1,776	$3,214,667
2023	281	1,525	$3,036,897
2024	322	1,567	$3,799,551

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	39	$4,661
2016	N/R	12	$1,956
2017	N/R	22	$6,495
2018	N/R	11	$207
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	71	$30,490
2022	N/R	310	$190,235
2023	N/R	110	$46,630
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	630	2,116	$10
36415	Insertion of needle into vein for collection of blood sample	632	2,737	$9
83550	Iron binding capacity	600	1,643	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	633	2,741	$8
83540	Iron level	600	1,643	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	47	1,316	$771,624
Verzenio	Abemaciclib	32	896	$451,180
Fruzaqla	Fruquintinib	14	392	$345,298
Lenvima	Lenvatinib Mesylate	11	330	$260,236
Erivedge	Vismodegib	14	404	$196,534

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	78	$1,660	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$454	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph M. Pascuzzo, DO?

Tedicare shows public-source Medicare data for Joseph M. Pascuzzo, DO (NPI 1538244314), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph M. Pascuzzo, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joseph M. Pascuzzo, DO?

Joseph M. Pascuzzo, DO is linked to CALIFORNIA CANCER ASSOCIATES FOR RESEARCH AND EXCELLENCE INC (billing NPI 1083661607) in the available physician profile data.

Does Joseph M. Pascuzzo, DO have Open Payments data?

Joseph M. Pascuzzo, DO has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.